A Phase 2, Multicenter, Non-Randomized, Open-Label Study of RVT-1401 for the Treatment of Patients with Warm Autoimmune Hemolytic Anemia
Latest Information Update: 01 Aug 2022
At a glance
- Drugs Batoclimab (Primary)
- Indications Autoimmune haemolytic anaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASCEND-WAIHA
- Sponsors Immunovant
Most Recent Events
- 06 Dec 2021 Status changed from suspended to discontinued due to Sponsor decision.
- 05 Nov 2021 This trial has been discontinued in Bulgaria and Spain (End Date: 12 Oct 2021), according to European Clinical Trials Database record.
- 28 Oct 2021 This trial has been completed in Hungary, according to Eudra record.